Southern Therapy and Advanced Research LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Primary biliary cholangitis2 trials
• Fatty liver disease (MASLD/MASH)1 trial
• Liver cirrhosis1 trial

Phase

• Phase 32 trials
• Phase 11 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Gilead Sciences2 trials
• Novo Nordisk A/S1 trial

Running trials

• Active, not recruiting

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· Phase 3· Novo Nordisk A/S· Source

• Active, not recruiting

  Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

  NCT03301506· Phase 3· Gilead Sciences· Source

Closed trials

• Completed

  An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

  NCT04950764· Phase 1· Gilead Sciences· Source